J7190
J7190 – Factor viii (antihemophilic factor, human) per i.u. · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 7 NDCs crosswalked per 1 IU $1.246/unit ASP+6%
📋 J7190 summary
J7190 is a HCPCS Level II J-code used to bill Factor viii (antihemophilic factor, human) per i.u., billed per 1 IU. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J7190: Hemofil M*, Hemofil M, Koate
Code J7190
Billing unit 1 IU Payment limit $1.246/unit NDC-Crosswalk 7
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ7190
DescriptorFactor viii (antihemophilic factor, human) per i.u.
Billing unit1 IU
Payment limit / unit$1.246
Est. ASP / unit$1.175 est.
Mapped NDCs7
Data periodQ3 2026
Last updated2026-08-20
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$1.246
Est. ASP / unit
$1.175 est.
Est. after 2% sequester
$1.221
HCPCS dosage
1 IU
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionFactor viii (antihemophilic factor, human) per i.u.
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date1999-01-01
Date added1986-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J7190 = 1 iu. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J7190 WITH EST. MEDICARE PAY
7 NDCs map to J7190. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.246/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00944-3940-02 | HEMOFIL M antihemophilic factor human KIT | Takeda | 1 KIT in 1 CARTON (0944-3940-02) * 10 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
| 00944-3942-02 | HEMOFIL M antihemophilic factor human KIT | Takeda | 1 KIT in 1 CARTON (0944-3942-02) * 10 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
| 00944-3944-02 | HEMOFIL M antihemophilic factor human KIT | Takeda | 1 KIT in 1 CARTON (0944-3944-02) * 10 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
| 00944-3946-02 | HEMOFIL M antihemophilic factor human KIT | Takeda | 1 KIT in 1 CARTON (0944-3946-02) * 10 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
| 76125-0257-25 | Koate ANTIHEMOPHILIC FACTOR (HUMAN) KIT | KEDRION | 1 KIT in 1 CARTON (76125-257-25) * 5 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
| 76125-0663-50 | Koate ANTIHEMOPHILIC FACTOR (HUMAN) KIT | KEDRION | 1 KIT in 1 CARTON (76125-663-50) * 5 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
| 76125-0679-12 | Koate ANTIHEMOPHILIC FACTOR (HUMAN) KIT | KEDRION | 1 KIT in 1 CARTON (76125-679-12) * 10 mL... | — | 1 | $1.25 | — | ● Active | CMS ASP |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$2.66M
Claims
72
Beneficiaries
14
Spend / beneficiary
$190,049.32
Spend / claim
$36,954.03
Trend by period
Where J7190 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #301 of 824
#296
YEZTUGO(J0738) J0738
$2.88M
#297
MYCOPHENOLIC ACID* J7518
$2.87M
#298
XCELL AMNIO MATRIX P... Q4280
$2.85M
#299
ZIIHERA J9276
$2.83M
#300
QALSODY J1304
$2.72M
#301
HEMOFIL M* J7190
$2.66M
#302
ZOLADEX J9202
$2.65M
#303
BELRAPZO* J9036
$2.6M
#304
JIVI J7208
$2.56M
#305
SUSVIMO J2779
$2.53M
#306
GELSYN-3 J7328
$2.43M
Total claims — #661 of 824
#656
THYMOGLOBULIN J7511
74
#657
NEBUPENT(J2516)* J2516
73
#658
WILATE J7183
73
#659
BIZENGRI J9382
73
#660
PRIMATRIX** Q4110
73
#661
HEMOFIL M* J7190
72
#662
EPIEFFECT, PER SQ CM... Q4278
72
#663
CONRAY Q9961
71
#664
ALKERAN* J9245
70
#665
NAFCILLIN SODIUM J2290
69
#666
ENGERIX-B PEDIATRIC-... 90744
68
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $2.66M | 14 | 72 | $190,049.32 | $36,954.03 |
| 2025 (Q1-Q4) | $13.44M | 46 | 345 | $292,160.27 | $38,954.70 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$12.78M
Medicare paid
$10.02M
Submitted services
8,072,095
Denial rate
0.8%
Allowed / service
$1.60
Submitted charges
$19.39M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk
7 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J7190 billing FAQ
What is HCPCS code J7190?
J7190 is a HCPCS Level II J-code used to bill Factor viii (antihemophilic factor, human) per i.u. under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J7190?
One unit of J7190 represents 1 IU. Report the number of units equal to the dose administered divided by 1 IU.
How many units of J7190 should I bill?
Divide the dose administered by the code's unit size (1 IU) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J7190?
The Medicare Part B payment limit is $1.246 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $1.221 per unit. Payment limits are revised quarterly.
Which NDCs bill under J7190?
7 NDCs currently map to J7190 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J7190 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.